The study by Jazaeri et al. (2002) has shown that there are considerable differences in transcriptome profiles in ovarian cancer patients bearing mutations in BRCA1 or BRCA2, which suggests activation of different mechanisms of the disease [19]. The gene discussed is BRCA1; the disease is ovarian cancer.